(Q37932206)

25 August 2017

1 reference

title

Whole cancer genome sequencing by next-generation methods (English)

1 reference

25 August 2017

whole genome sequencing

1 reference

based on heuristic

inferred from title

Cancer genome sequencing

1 reference

Jeffrey S Ross

1

1 reference

PubMed ID

21917674

25 August 2017

Maureen Cronin

series ordinal

2

1 reference

PubMed ID

21917674

American Journal of Clinical Pathology

25 August 2017

language of work or name

English

1 reference

inferred from

publication date

1 October 2011

1 reference

American Journal of Clinical Pathology

25 August 2017

1 reference

25 August 2017

136

1 reference

25 August 2017

527-539

1 reference

25 August 2017

4

1 reference

Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma

25 August 2017

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

The role of companion diagnostics in the development and use of mutation-targeted cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Crizotinib--latest champion in the cancer wars?

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Inherited predisposition to cancer: introduction and overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Cancer predisposition syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Pharmacogenomics of tamoxifen and irinotecan therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Cancer genome sequencing: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

From genomic landscapes to personalized cancer management-is there a roadmap?

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Clinical cancer genomics: how soon is now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

DNA sequencing with chain-terminating inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Initial sequencing and analysis of the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Finishing the euchromatic sequence of the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

What's new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Biomarker-based prediction of response to therapy for colorectal cancer: current perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

KRAS genotyping of paraffin-embedded colorectal cancer tissue in routine diagnostics: comparison of methods and impact of histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Targeting anaplastic lymphoma kinase in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

ALK inhibition for non-small cell lung cancer: from discovery to therapy in record time

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Clinical implications of KIT and PDGFRA genotyping in GIST.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

The GIST paradigm: lessons for other kinase-driven cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Targeting KIT in melanoma: a paradigm of molecular medicine and targeted therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Clinical implications of the cancer genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Applications of genomics in melanoma oncogene discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

A sequencing method based on real-time pyrophosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Pyrosequencing: history, biochemistry and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Pyrosequencing for discovery and analysis of DNA sequence variations

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

DNA analysis by MALDI-TOF mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Mass-spectrometry DNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Genotyping single nucleotide polymorphisms by MALDI mass spectrometry in clinical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Real time quantitative PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Product differentiation by analysis of DNA melting curves during the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Next-generation sequencing transforms today's biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Next-generation sequencing: from basic research to diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Advances in understanding cancer genomes through second-generation sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

The power of NGS technologies to delineate the genome organization in cancer: from mutations to structural variations and epigenetic alterations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Sequencing technologies - the next generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Next-generation DNA sequencing methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Alta-Cyclic: a self-optimizing base caller for next-generation sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

A large genome center's improvements to the Illumina sequencing system

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Analysis of next-generation genomic data in cancer: accomplishments and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Man-made cell-like compartments for molecular evolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Accurate multiplex polony sequencing of an evolved bacterial genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Sequence information can be obtained from single DNA molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Detection and removal of biases in the analysis of next-generation sequencing reads

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

A practical, bioinformatic workflow system for large data sets generated by next-generation sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Challenges of sequencing human genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Rapid quantification of DNA libraries for next-generation sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Systematic comparison of three genomic enrichment methods for massively parallel DNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

Effect of fixatives and tissue processing on the content and integrity of nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

DNA degradation test predicts success in whole-genome amplification from diverse clinical samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPR1SVT1VHUGXW

21 January 2018

Identifiers

DOI

10.1309/AJCPR1SVT1VHUGXW

1 reference

25 August 2017

1 reference

PubMed ID

21917674